# Prospective, Multicenter, Randomized Controlled Clinical Study Evaluating the VitaFlow Liberty® Flex Transcatheter Aortic Valve Delivery System for the Treatment of Severe Aortic Stenosis Lesions

> **NCT07145463** · NA · RECRUITING · sponsor: **Shanghai Zhongshan Hospital** · enrollment: 232 (estimated)

## Conditions studied

- Aortic Valve Stenosis

## Interventions

- **DEVICE:** Transcatheter Aortic Valve Replacement

## Key facts

- **NCT ID:** NCT07145463
- **Lead sponsor:** Shanghai Zhongshan Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-07-30
- **Primary completion:** 2026-08-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 232 (ESTIMATED)
- **Last updated:** 2025-08-28

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07145463

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07145463, "Prospective, Multicenter, Randomized Controlled Clinical Study Evaluating the VitaFlow Liberty® Flex Transcatheter Aortic Valve Delivery System for the Treatment of Severe Aortic Stenosis Lesions". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT07145463. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*